TY - JOUR AU - Sengupta, Krishanu AU - Alluri, Krishnaraju V. AU - Satish, Andey Rama AU - Mishra, Simanchala AU - Golakoti, Trimurtulu AU - Sarma, Kadainti VS AU - Dey, Dipak AU - Raychaudhuri, Siba P. PY - 2008 DA - 2008/07/30 TI - A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin®for treatment of osteoarthritis of the knee JO - Arthritis Research & Therapy SP - R85 VL - 10 IS - 4 AB - 5-Loxin® is a novel Boswellia serrata extract enriched with 30% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA), which exhibits potential anti-inflammatory properties by inhibiting the 5-lipoxygenase enzyme. A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the efficacy and safety of 5-Loxin® in the treatment of osteoarthritis (OA) of the knee. SN - 1478-6354 UR - https://doi.org/10.1186/ar2461 DO - 10.1186/ar2461 ID - Sengupta2008 ER -